| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
We’re creative and passionate professionals on a mission – to deliver top-notch natural health products to a global community. 🍃💪
Scherago International is a Jersey City, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Isto Technologies, Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Saint Louis, MO. To find more information about Isto Technologies, Inc, please visit www.istotech.com
CitiMed is a healthcare provider with over 100 board certified healthcare providers offering a full range of medical services, including primary care, neurosurgery, and pain management, with 20 locations in Queens, the Bronx, and White Plains.